GRANISETRON
Substance profile for UNII WZG3J2MCOL, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from NCI/CADD chemical resolverSubstance Identity#
- UNII
- WZG3J2MCOL
- Preferred term
- GRANISETRON
- Registry number
- 109889-09-0
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C18H24N4O
Structure render from NCI/CADD chemical resolverChemical And Database Identifiers#
- InChIKey
- MFWNKCLOYSRHCJ-BTTYYORXSA-N
- SMILES
- CN1N=C(C(=O)N[C@@H]2C[C@@H]3CCC[C@H](C2)N3C)C4=C1C=CC=C4
- RxCUI
- 26237
- PubChem
- 0
- NCIt
- C62031
- INN ID
- 6230
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| GRANISETRON | ACTIVE MOIETY | WZG3J2MCOL | These highlights do not include all the information needed to use granisetron hydrochloride injection safely and effectively. See full prescribing information for granisetron hydrochloride injection. Granisetron Hydrochloride Injection, USP, for intravenous use Initial U.S. Approval: 1993 | 2 | |
| GRANISETRON | ACTIVE MOIETY | WZG3J2MCOL | These highlights do not include all the information needed to use granisetron hydrochloride injection safely and effectively. See full prescribing information for granisetron hydrochloride injection. Granisetron Hydrochloride Injection, USP, for intravenous use Initial U.S. Approval: 1993 | 1 | |
| GRANISETRON | ACTIVE MOIETY | WZG3J2MCOL | These highlights do not include all the information needed to use granisetron hydrochloride injection safely and effectively. See full prescribing information for granisetron hydrochloride injection. Granisetron Hydrochloride Injection, USP, for intravenous use Initial U.S. Approval: 1993 | 1 | |
| GRANISETRON | ACTIVE MOIETY | WZG3J2MCOL | Granisetron hydrochloride tablets | 4 | |
| GRANISETRON | ACTIVE MOIETY | WZG3J2MCOL | These highlights do not include all the information needed to use Sancuso (Granisetron Transdermal System) safely and effectively. See full prescribing information for Sancuso. Sancuso (Granisetron Transdermal System) Initial U.S. Approval: 2008 | 5 | |
| GRANISETRON | ACTIVE INGREDIENT | WZG3J2MCOL | These highlights do not include all the information needed to use Sancuso (Granisetron Transdermal System) safely and effectively. See full prescribing information for Sancuso. Sancuso (Granisetron Transdermal System) Initial U.S. Approval: 2008 | 5 | |
| granisetron | ACTIVE MOIETY | WZG3J2MCOL | GRANISETRON HYDROCHLORIDE INJECTION, SOLUTION [SAGENT PHARMACEUTICALS] | 16 | |
| GRANISETRON | ACTIVE MOIETY | WZG3J2MCOL | GRANISETRON INJECTION [SANDOZ INC] | 16 | |
| granisetron | ACTIVE MOIETY | WZG3J2MCOL | GRANISETRON HYDROCHLORIDE INJECTION, SOLUTION [SAGENT PHARMACEUTICALS] | 15 | |
| GRANISETRON | ACTIVE MOIETY | WZG3J2MCOL | GRANISETRON HYDROCHLORIDE TABLET, FILM COATED [NORTHSTAR RX LLC] | 9 | |
| GRANISETRON | ACTIVE INGREDIENT | WZG3J2MCOL | SANCUSO (GRANISETRON) PATCH [PROSTRAKAN, INC.] | 9 | |
| GRANISETRON | ACTIVE MOIETY | WZG3J2MCOL | SANCUSO (GRANISETRON) PATCH [PROSTRAKAN, INC.] | 9 | |
| Granisetron | ACTIVE MOIETY | WZG3J2MCOL | GRANISETRON HYDROCHLORIDE INJECTION [AKORN, INC.] | 8 | |
| GRANISETRON | ACTIVE MOIETY | WZG3J2MCOL | GRANISETRON HYDROCHLORIDE INJECTION [WEST-WARD PHARMACEUTICAL CORP] | 7 | |
| GRANISETRON | ACTIVE MOIETY | WZG3J2MCOL | GRANISETRON HYDROCHLORIDE TABLET, FILM COATED [COREPHARMA, LLC] | 7 | |
| GRANISETRON | ACTIVE MOIETY | WZG3J2MCOL | GRANISETRON HYDROCHLORIDE TABLET, FILM COATED [NORTHSTAR RX LLC] | 7 | |
| Granisetron | ACTIVE MOIETY | WZG3J2MCOL | GRANISETRON HYDROCHLORIDE TABLET, FILM COATED [TARO PHARMACEUTICALS U.S.A., INC.] | 7 | |
| GRANISETRON | ACTIVE MOIETY | WZG3J2MCOL | GRANISETRON HYDROCHLORIDE TABLET [ROXANE LABORATORIES, INC] | 6 | |
| GRANISETRON | ACTIVE MOIETY | WZG3J2MCOL | GRANISETRON HYDROCHLORIDE TABLET, FILM COATED [TEVA PHARMACEUTICALS USA INC] | 6 | |
| GRANISETRON | ACTIVE MOIETY | WZG3J2MCOL | GRANISETRON (GRANISETRON HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 5 | |
| granisetron | ACTIVE MOIETY | WZG3J2MCOL | GRANISETRON HYDROCHLORIDE INJECTION, SOLUTION [SAGENT PHARMACEUTICALS] | 4 | |
| GRANISETRON | ACTIVE MOIETY | WZG3J2MCOL | GRANISETRON HYDROCHLORIDE INJECTION [CIPLA LIMITED] | 3 | |
| GRANISETRON | ACTIVE MOIETY | WZG3J2MCOL | GRANISETRON HYDROCHLORIDE INJECTION [CIPLA USA INC.] | 3 | |
| GRANISETRON | ACTIVE MOIETY | WZG3J2MCOL | GRANISETRON HYDROCHLORIDE TABLET [BRECKENRIDGE PHARMACEUTICAL, INC.] | 3 | |
| GRANISETRON | ACTIVE MOIETY | WZG3J2MCOL | GRANISETRON HYDROCHLORIDE INJECTION [WOCKHARDT USA LLC] | 2 | |
| GRANISETRON | ACTIVE MOIETY | WZG3J2MCOL | GRANISETRON HYDROCHLORIDE INJECTION [WOCKHARDT USA LLC] | 1 | |
| GRANISETRON | ACTIVE MOIETY | WZG3J2MCOL | GRANISETRON HYDROCHLORIDE INJECTION [WOCKHARDT USA LLC] | 1 | |